Literature DB >> 26334839

Taq DNA Polymerase Mutants and 2'-Modified Sugar Recognition.

Hayley J Schultz1, Andrea M Gochi1, Hannah E Chia1, Alexie L Ogonowsky1, Sharon Chiang1, Nedim Filipovic1, Aurora G Weiden1, Emma E Hadley1, Sara E Gabriel1, Aaron M Leconte1.   

Abstract

Chemical modifications to DNA, such as 2' modifications, are expected to increase the biotechnological utility of DNA; however, these modified forms of DNA are limited by their inability to be effectively synthesized by DNA polymerase enzymes. Previous efforts have identified mutant Thermus aquaticus DNA polymerase I (Taq) enzymes capable of recognizing 2'-modified DNA nucleotides. While these mutant enzymes recognize these modified nucleotides, they are not capable of synthesizing full length modified DNA; thus, further engineering is required for these enzymes. Here, we describe comparative biochemical studies that identify useful, but previously uncharacterized, properties of these enzymes; one enzyme, SFM19, is able to recognize a range of 2'-modified nucleotides much wider than that previously examined, including fluoro, azido, and amino modifications. To understand the molecular origins of these differences, we also identify specific amino acids and combinations of amino acids that contribute most to the previously evolved unnatural activity. Our data suggest that a negatively charged amino acid at 614 and mutation of the steric gate residue, E615, to glycine make up the optimal combination for modified oligonucleotide synthesis. These studies yield an improved understanding of the mutational origins of 2'-modified substrate recognition as well as identify SFM19 as the best candidate for further engineering, whether via rational design or directed evolution.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26334839     DOI: 10.1021/acs.biochem.5b00689

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis.

Authors:  Eliza L Lewis; Aaron M Leconte
Journal:  J Vis Exp       Date:  2017-10-06       Impact factor: 1.355

2.  Enzymatic synthesis of random sequences of RNA and RNA analogues by DNA polymerase theta mutants for the generation of aptamer libraries.

Authors:  Irina Randrianjatovo-Gbalou; Sandrine Rosario; Odile Sismeiro; Hugo Varet; Rachel Legendre; Jean-Yves Coppée; Valérie Huteau; Sylvie Pochet; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

Review 3.  G-quadruplex-based aptamers against protein targets in therapy and diagnostics.

Authors:  Chiara Platella; Claudia Riccardi; Daniela Montesarchio; Giovanni N Roviello; Domenica Musumeci
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-11-16       Impact factor: 3.770

4.  Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications.

Authors:  Adeline Espinasse; Hannah K Lembke; Angela A Cao; Erin E Carlson
Journal:  RSC Chem Biol       Date:  2020-09-14

5.  Mutant polymerases capable of 2' fluoro-modified nucleic acid synthesis and amplification with improved accuracy.

Authors:  Trevor A Christensen; Kristi Y Lee; Simone Z P Gottlieb; Mikayla B Carrier; Aaron M Leconte
Journal:  RSC Chem Biol       Date:  2022-06-17

Review 6.  Modified Nucleoside Triphosphates for In-vitro Selection Techniques.

Authors:  María A Dellafiore; Javier M Montserrat; Adolfo M Iribarren
Journal:  Front Chem       Date:  2016-05-04       Impact factor: 5.221

Review 7.  Modified nucleic acids: replication, evolution, and next-generation therapeutics.

Authors:  Karen Duffy; Sebastian Arangundy-Franklin; Philipp Holliger
Journal:  BMC Biol       Date:  2020-09-02       Impact factor: 7.431

Review 8.  Building better polymerases: Engineering the replication of expanded genetic alphabets.

Authors:  Zahra Ouaray; Steven A Benner; Millie M Georgiadis; Nigel G J Richards
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.